When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 16 Mar 2025
Last updated: 22 Aug 2023

Summary

Definition

History and exam

Key diagnostic factors

  • presence of risk factors
  • chronic watery, non-bloody diarrhoea

Other diagnostic factors

  • faecal urgency
  • faecal incontinence
  • nocturnal stools
  • abdominal pain
  • weight loss
  • bloating
  • fatigue

Risk factors

  • age >50 years
  • cigarette smoking
  • female sex
  • autoimmune disorders
  • use of certain medications

Diagnostic investigations

1st investigations to order

  • FBC
  • basic metabolic panel
  • CRP
  • erythrocyte sedimentation rate
  • immunoglobulin A-tissue transglutaminase
  • stool studies for infective pathogens
  • stool O+P
  • lateral flow immunoassay (Giardia)
  • ileocolonoscopy
  • colonic biopsies

Investigations to consider

  • flexible sigmoidoscopy with biopsies

Treatment algorithm

Contributors

Authors

Darrell Pardi, MD

Professor of Medicine and Chair

Division of Gastroenterology and Hepatology

Department of Internal Medicine

Mayo Clinic

Rochester

MN

Disclosures

DP declares they have undertaken general consulting for Otsuka Pharmaceutical Development and Commercialization, Inc., Immunic Therapeutics, Rise Therapeutics, and Phathom Pharmaceuticals, Inc. DP has been on advisory boards for AbbVie, Inc., 3D Communications, Et al. Scientific, Summit Therapeutics, Boehringer Ingelheim Pharmaceuticals, Inc., and Ferring Pharmaceuticals, Inc. DP has received grants (to their institution) for research projects from Rise Therapeutics, Seres Therapeutics, Pfizer, and Alimentiv. DP is the author of references cited in this topic.

Sahil Khanna, MBBS, MS

Professor of Medicine

Division of Gastroenterology and Hepatology

Department of Internal Medicine

Mayo Clinic

Rochester

MN

Disclosures

SK declares no competing interests.

Raseen Tariq, MBBS

Instructor in Medicine

Division of Gastroenterology and Hepatology

Department of Internal Medicine

Mayo Clinic

Rochester

MN

Disclosures

RT declares no competing interests.

Peer reviewers

David S. Sanders, MB, ChB, MD, FRCP, FACG

Chair of the Coeliac UK Health Advisory Council

Honorary Professor of Gastroenterology

University of Sheffield

Consultant Gastroenterologist

Sheffield Teaching Hospitals NHS Foundation Trust

Sheffield

UK

Disclosures

DSS declares that he has no competing interests.

Joseph D Feuerstein, MD

Attending in Gastroenterology

Beth Israel Deaconess Medical Center

Associate Professor of Medicine

Harvard Medical School

Boston

MA

Disclosures

JDF declares no competing interests.

Use of this content is subject to our disclaimer